January 2008 | Oncology & Biotech News

June 25, 2010

The Academy delivers the latest news on biotech and oncoloy research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery.

June 25, 2010

A collection of statistics and facts on skin cancer and melanoma

June 25, 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue: 1) Bristol-Myers Squibb: BMS Boasts Bright Oncology Future 2) Infinity Pharmaceuticals and AstraZeneca: Prostate Cancer Partnership Begins to Bear Fruit 3) Genentech: Avastin Shown To Halt Brain Cancer Progress, and more

June 25, 2010

Topics covered in this issue include: 1) Dosing Patterns and Costs of Erythropoesis-Stimulating Agents in Patients With Cancer 2) New Practice Guideline Updates Treatment of Non-Small Cell Lung Cancer 3) Large Health Insurer Begins Genetic Risk Counseling for Cancer, and more

June 24, 2010

The Clinical Trials reported in this issue include: PHASE III: 1) Atamestane Plus Toremifene Compared With Letrozole for Advanced Receptor-Positive Breast Cancer Treatment 2) Tamoxifen Superior to Arzoxifene for Locally Advanced or Metastatic Breast Cancer 3) Head and Neck Cancer Treatment With Cisplatin, Fluorouracil, and Docetaxel, and more

June 24, 2010

Articles in this issue include: Sweden: What Do Genes Have to Do With Cancer Survival? United Kingdom: 1) New Renal Sarcoma Type Characterized 2) Vinflunine for the Treatment of Malignant Pleural Mesothelioma, and more

June 24, 2010

Each year, more than 60,000 people are diagnosed with bladder cancer, which has been linked to a number of risk factors, including cigarette smoking and exposure to hazardous chemicals.

June 24, 2010

2008's Chemotherapy Foundation Symposium

June 23, 2010

In this month's issue of Oncology & Biotech News, we report on the Chemotherapy Foundation Symposium, which was held in New York City. This excellent meeting highlighted emerging therapies in cancer treatment and the ways in which these treatments are changing our views and management of cancer.